Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$5.91 - $14.38 $229,012 - $557,225
-38,750 Closed
0 $0
Q4 2021

Jan 10, 2022

BUY
$5.21 - $8.61 $181,047 - $299,197
34,750 Added 868.75%
38,750 $249,000
Q3 2021

Nov 24, 2021

BUY
$4.45 - $10.63 $2,670 - $6,378
600 Added 17.65%
4,000 $23,000
Q2 2021

Jul 30, 2021

BUY
$8.11 - $11.11 $9,732 - $13,332
1,200 Added 54.55%
3,400 $35,000
Q1 2021

Apr 29, 2021

BUY
$9.85 - $17.69 $21,670 - $38,918
2,200 New
2,200 $23,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.